$20.18
-2.19-9.79%
Last update: Nov 12, 4:03 PM
Assembly Biosciences Inc
ASMBNASDAQ
Assembly Biosciences fell 37.6% from $35.85 to $22.37, behind the S&P 500's +10.8%. Its worst day was Oct 13 (−10.7%), and its low came Nov 2 at $19.51.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Assembly Biosciences closed at its highest level of the year, 7.4% above where the year started.
+4.8% · S&P 500 +1.0%
Assembly Biosciences shares fell 9.5%, while the S&P 500 rose 0.5%.
−9.5% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
Assembly Biosciences shares rose 10.7%, while the S&P 500 rose 0.7%.
+10.7%, the year's best day · S&P 500 +0.7%
EPS of $1.30 beat the $-0.71 estimate on $42.5M revenue (est. $8.7M).
+3.5% · S&P 500 −1.4%
EPS of $-0.54 beat the $-0.66 estimate on $8.2M revenue (est. $7.4M).
−3.8% · S&P 500 +0.8%
Assembly Biosciences shares rose 10.2%, while the S&P 500 fell 0.7%.
+10.2%, on 2M shares, the year's heaviest volume · S&P 500 −0.7%
EPS of $-0.20 beat the $-0.56 estimate on $13.4M revenue (est. $7.0M).
+10.0% · S&P 500 −0.2%
Assembly Biosciences shares fell 9.8%, while the S&P 500 fell 0.5%.
−9.8% · S&P 500 −0.5%
Assembly Biosciences shares fell 10.7%, while the S&P 500 fell 0.0%.
−10.7%, the year's worst day · S&P 500 0.0%
Assembly Biosciences closed at its lowest level of the year, 45.6% below where the year started.
−3.1% · S&P 500 −0.5%
Where it ended: a close of $22.37 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.48, revenue est. $7.4M).
Nothing in the past 12 months.
All ASMB dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ASMB and SPY from Benzinga historical bars. Not investment advice.
